Skip to content
sellWeak10b5-1 plan

Dominick Colangelo sold $2.1M of VCEL

President and CEO at Vericel Corp. 49,700 shares at an average of $41.50, traded Apr 9, 2025, filed Apr 11, 2025.

Warning score
20
Value
$2.1M
49,700 shares
Holdings after
260,354
-17% from before
From 52-week low
+15%
low $38.60, close $44.24
From 52-week high
-28%
high $61.80, as of Apr 9, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $2.1M at market
    +25
  • Share of holdings sold
    Sold 17% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +1.2%, 3m -3.2%, 6m -22.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

VCELOct 12, 2026 · close 40.62
Since filing Apr 11, 2025: -1.5%SPY +48.1% · excess -49.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001140361-25-013471, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 9, 2025MOption exercise
Common Stock10b5-1
+24,850$2.75$68k285,204Apr 11, 2025
Apr 9, 2025SOpen-market sale
Common Stock10b5-1
-24,850$41.11$1.0M260,354Apr 11, 2025
Apr 10, 2025MOption exercise
Common Stock10b5-1
+24,850$2.75$68k285,204Apr 11, 2025
Apr 10, 2025SOpen-market sale
Common Stock10b5-1
-24,850$41.89$1.0M260,354Apr 11, 2025
Apr 9, 2025MOption exercise
Stock Option (Right to Buy)derivative10b5-1
+24,850$0.00$024,850Apr 11, 2025
Apr 10, 2025MOption exercise
Stock Option (Right to Buy)derivative10b5-1
+24,850$0.00$00Apr 11, 2025

Related signals

Other insiders at Vericel Corp and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
19Weak
VCELsell 310b5-1
Vericel Corp
Kevin F McLaughlin
director
$312k
7,000 shares
-28%
27Weak
VCELsell 310b5-1
Vericel Corp
Michael Halpin
Chief Operating Officer
$468k
10,000 shares
-38%
27Weak
VCELsell 310b5-1
Vericel Corp
Jonathan Siegal
Principal Accounting Officer
$220k
4,500 shares
-175%
36Weak
VCELsell 510b5-1
Vericel Corp
Sean C. Flynn
Chief Legal Officer
$685k
15,000 shares
-90%
17Weak
VCELsell 510b5-1
Vericel Corp
Jonathan Mark Hopper
Chief Medical Officer
$450k
10,000 shares
-12%
34Weak
VCELsell 510b5-1
Vericel Corp
Joseph Anthony Mara Jr
Chief Financial Officer
$224k
5,000 shares
-24%
25Weak
VCELsell 510b5-1
Vericel Corp
Jonathan Siegal
Principal Accounting Officer
$123k
2,732 shares
-244%
34Weak
VCELsell 510b5-1
Vericel Corp
Sean C. Flynn
Chief Legal Officer
$603k
15,000 shares
-90%
26Weak
VCELsell 510b5-1
Vericel Corp
Michael Halpin
Chief Operating Officer
$402k
10,000 shares
-38%
0Weak
VCELsell10b5-1
Vericel Corp
Jonathan Mark Hopper
Chief Medical Officer
$153k
4,375 shares
-5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dominick Colangelo sold $2.1M of VCEL | InsiderTell